BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28378397)

  • 1. Relationship among LRP1 expression, Pyk2 phosphorylation and MMP-9 activation in left ventricular remodelling after myocardial infarction.
    Revuelta-López E; Soler-Botija C; Nasarre L; Benitez-Amaro A; de Gonzalo-Calvo D; Bayes-Genis A; Llorente-Cortés V
    J Cell Mol Med; 2017 Sep; 21(9):1915-1928. PubMed ID: 28378397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.
    Revuelta-López E; Castellano J; Roura S; Gálvez-Montón C; Nasarre L; Benitez S; Bayes-Genis A; Badimon L; Llorente-Cortés V
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2877-87. PubMed ID: 24072693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-driven sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) downregulation depends on low-density lipoprotein receptor-related protein 1 (LRP1)-signalling in cardiomyocytes.
    Revuelta-López E; Cal R; Herraiz-Martínez A; de Gonzalo-Calvo D; Nasarre L; Roura S; Gálvez-Montón C; Bayes-Genis A; Badimon L; Hove-Madsen L; Llorente-Cortés V
    J Mol Cell Cardiol; 2015 Aug; 85():25-36. PubMed ID: 25968337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
    Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
    Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient expression of cellular retinol-binding protein-1 during cardiac repair after myocardial infarction.
    Yu M; Ishibashi-Ueda H; Ohta-Ogo K; Gabbiani G; Yamagishi M; Hayashi K; Hirota S; Bochaton-Piallat ML; Hao H
    Pathol Int; 2012 Apr; 62(4):246-53. PubMed ID: 22449228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion.
    Cheng Z; Ou L; Liu Y; Liu X; Li F; Sun B; Che Y; Kong D; Yu Y; Steinhoff G
    Cardiovasc Res; 2008 Dec; 80(3):425-34. PubMed ID: 18676396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.
    Ghali R; Habeichi NJ; Kaplan A; Tannous C; Abidi E; Bekdash A; Farhat R; Itani H; Jurjus A; Booz GW; Mallat Z; Zouein FA
    Clin Sci (Lond); 2020 Jun; 134(11):1191-1218. PubMed ID: 32432676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
    Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
    Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome.
    Liu W; Zhang X; Zhao M; Zhang X; Chi J; Liu Y; Lin F; Fu Y; Ma D; Yin X
    Cell Physiol Biochem; 2015; 35(6):2483-500. PubMed ID: 25967877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
    Mukherjee R; Mingoia JT; Bruce JA; Austin JS; Stroud RE; Escobar GP; McClister DM; Allen CM; Alfonso-Jaume MA; Fini ME; Lovett DH; Spinale FG
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2216-28. PubMed ID: 16766634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
    Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
    J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
    Mani SK; Kern CB; Kimbrough D; Addy B; Kasiganesan H; Rivers WT; Patel RK; Chou JC; Spinale FG; Mukherjee R; Menick DR
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1391-401. PubMed ID: 25795711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.
    Podesser BK; Siwik DA; Eberli FR; Sam F; Ngoy S; Lambert J; Ngo K; Apstein CS; Colucci WS
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H984-91. PubMed ID: 11179039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling.
    Jiang B; Chen J; Xu L; Gao Z; Deng Y; Wang Y; Xu F; Shen X; Guo DA
    BMC Pharmacol; 2010 Aug; 10():10. PubMed ID: 20735854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
    Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
    Nie R; Xie S; Du B; Liu X; Deng B; Wang J
    Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.
    Li L; Wang X; Chen W; Qi H; Jiang DS; Huang L; Huang F; Wang L; Li H; Chen X
    Basic Res Cardiol; 2015 Nov; 110(6):56. PubMed ID: 26463597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.